1. Home
  2. ANAB vs LSPD Comparison

ANAB vs LSPD Comparison

Compare ANAB & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$53.61

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Lightspeed Commerce Inc. Subordinate Voting Shares

LSPD

Lightspeed Commerce Inc. Subordinate Voting Shares

HOLD

Current Price

$10.31

Market Cap

1.4B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
LSPD
Founded
2005
2005
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ANAB
LSPD
Price
$53.61
$10.31
Analyst Decision
Buy
Buy
Analyst Count
12
9
Target Price
$71.67
$13.33
AVG Volume (30 Days)
818.3K
733.8K
Earning Date
05-08-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
91.02
N/A
EPS
N/A
N/A
Revenue
$234,603,000.00
N/A
Revenue This Year
N/A
$15.43
Revenue Next Year
$52.14
$10.94
P/E Ratio
N/A
N/A
Revenue Growth
157.01
N/A
52 Week Low
$17.11
$7.83
52 Week High
$73.30
$14.34

Technical Indicators

Market Signals
Indicator
ANAB
LSPD
Relative Strength Index (RSI) 44.82 55.59
Support Level $52.32 $8.97
Resistance Level $57.70 $11.00
Average True Range (ATR) 4.55 0.34
MACD -0.98 -0.07
Stochastic Oscillator 24.72 71.07

Price Performance

Historical Comparison
ANAB
LSPD

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc is a one-stop commerce platform providing its customers with the critical functionalities needed to engage with consumers, manage their operations, order their inventory, accept payments, and run their business. It has customers globally in over 100 countries, empowering single- and multi-location small and medium-sized businesses to compete in an omni-channel market environment by engaging with consumers across online, mobile, social, and physical channels. Its products are divided into retail, restaurant, and golf categories. Geographically, it operates in Canada, the United States, the United Kingdom, Switzerland, Germany, and Others with the majority of revenue deriving from Canada.

Share on Social Networks: